Application and progress of artificial intelligence in diagnosis and treatment of hepatobiliary and pancreatic tumors

doi:10.3877/cma.j.issn.1674-6899.2025.03.008

Abstract

Abstract:

In the era of rapid development of science and technology, the relationship between artificial intelligence (AI) and medicine has become increasingly close, and the integration of the above two has greatly promoted the rapid development of disease diagnosis and treatment. At present, AI has been applied in the diagnosis and treatment of clinical diseases, and its application in hepatobiliary and pancreatic surgery is developing rapidly, providing vital technical support and guarantee for the diagnosis of hepatobiliary and pancreatic tumors, treatment plan decision-making, surgical safety and accuracy, tumor pathology, treatment prognosis, and simulation training of surgeons. This article reviews the application and research progress of AI in the treatment of hepatobiliary and pancreatic tumors, in order to provide a new direction for the accurate and minimally invasive diagnosis and treatment of hepatobiliary and pancreatic tumors.

Key words: Artificial intelligence, Hepatobiliary and pancreatic surgery, Deep learning, Tumor

Longfu Xi, Rongquan Xue. Application and progress of artificial intelligence in diagnosis and treatment of hepatobiliary and pancreatic tumors[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2025, 18(03): 166-171.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6899.2025.03.008

https://zhqjwkzz.cma-cmc.com.cn/EN/Y2025/V18/I03/166

References 48

1	方驰华，田捷，张鹏，等. 数字医学技术在肝胆胰外科的应用：20年历史回顾与未来展望[J].中华外科杂志，2021, 59(10):807-811.
2	Nagtegaal ID, Odze RD, Klimstra D, et al. WHO classification of tumours editorial board；the 2019 WHO classification of tumours of the digestive system[J]. Histopathology, 2020, 76(2): 182-188.
3	Gao R, Zhao S, Aishanjiang K, et al. Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data[J]. J Hematol Oncol, 2021, 14(1): 154.
4	Xia TY, Zhou ZH, Meng XP, et al. Predicting microvascular invasion in hepatocellular carcinoma using CT-based radiomics model[J]. Radiology, 2023, 307(4): e222729.
5	Takamoto T, Ban D, Nara S, et al. Automated three-dimensional liver reconstruction with artificial intelligence for virtual hepatectomy[J]. J Gastrointest Surg, 2022, 26(10): 2119-2127.
6	Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria[J]. Ann Surg, 2011, 254(1): 108-113.
7	Chu T, Zhao C, Zhang J, et al. Application of a convolutional neural network for multitask learning to simultaneously predict microvascular invasion and vessels that encapsulate tumor clusters in hepatocellular carcinoma[J]. Ann Surg Oncol, 2022, 29(11): 6774-6783.
8	Sarcognato S, Sacchi D, Fassan M, et al. Cholangiocarcinoma[J]. Pathologica, 2021, 113(3): 158-169.
9	Cheng M, Zhang H, Guo Y，et al. Comparison of MRI and CT based deep learning radiomics analyses and their combination for diagnosing intrahepatic cholangiocarcinoma[J]. Sci Rep, 2025, 15(1): 9629.
10	Xiang F, Meng QT, Deng JJ, et al., A deep learning model based on contrast-enhanced computed tomography for differential diagnosis of gallbladder carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 376-384.
11	Egawa S, Toma H, Ohigashi H, et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society[J]. Pancreas, 2012, 41(7): 985-992.
12	Maguchi H. The roles of endoscopic ultrasonography in the diagnosis of pancreatic tumors[J]. J Hepatobiliary Pancreat Surg, 2004, 11(1): 1-3.
13	Tonozuka R, Itoi T, Nagata N, et al. Deep learning analysis for the detection of pancreatic cancer on endosonographic images: a pilot study[J]. J Hepatobiliary Pancreat Sci, 2021, 28(1): 95-104.
14	Akmese OF. Data privacy-aware machine learning approach in pancreatic cancer diagnosis[J]. BMC Med Inform Decis Mak, 2024, 24(1): 248.
15	Cao K, Xia Y, Yao J, et al. Large-scale pancreatic cancer detection via non-contrast CT and deep learning[J]. Nat Med, 2023, 29(12): 3033-3043.
16	Ratti F, Serenari M, Corallino D, et al., Augmented reality improving intraoperative navigation in minimally invasive liver surgery: an interplay between 3D reconstruction and indocyanine green[J]. Updates Surg, 2024, 76(7): 2701-2708.
17	许阳，成剑文，王鹏翔，等. 腹腔镜下肝脏手术增强现实三维影像导航平台的构建与应用[J]. 中国临床医学，2023, 30(1): 97-103.
18	Yang L, Chen Y, Ling S, et al. Research progress on the application of optical coherence tomography in the field of oncology[J]. Front Oncol, 2022, 12: 953934.
19	Scholler J, Groux K, Goureau O, et al. Dynamic full-field optical coherence tomography: 3D live-imaging of retinal organoids[J]. Light Sci Appl, 2020, 9: 140.
20	Pavone M, Innocenzi C, Carles E, et al. Cutting edge microscopic intraoperative tissue assessment for guidance in oncologic surgery: a systematic review of the role of optical coherence tomography[J]. Ann Surg Oncol, 2025, 32(3): 2191-2205.
21	Kawaguchi Y, Hasegawa K, Tzeng CD, et al. Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity[J]. Br J Surg, 2020, 107(3): 258-267.
22	Laino ME, Fiz F, Morandini P, et al. A virtual biopsy of liver parenchyma to predict the outcome of liver resection[J]. Updates Surg, 2023, 75(6): 1519-1531.
23	Villanueva A. Hepatocellular carcinoma[J]. N Engl J Med, 2019, 380(15): 1450-1462.
24	Wang Y, Ge H, Hu M, et al. Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: a retrospective propensity score-matched study[J]. Int J Surg, 2022, 105: 106852.
25	Sun X, Wang Y, Ge H, et al. Development and validation of novel models including tumor micronecrosis for predicting the postoperative survival of patients with hepatocellular carcinoma[J]. J Hepatocell Carcinoma, 2023, 10: 1181-1194.
26	Deng B, Tian Y, Zhang Q, et al. NecroGlobalGCN: integrating micronecrosis information in HCC prognosis prediction via graph convolutional neural networks[J]. Comput Methods Programs Biomed, 2024, 257: 108435.
27	Ohri N, Dawson LA, Krishnan S, et al. Radiotherapy for hepatocellular carcinoma: new indications and directions for future study[J]. J Natl Cancer Inst, 2016, 108(9).
28	Sun J, Huang L, Liu Y. Leveraging SEER data through machine learning to predict distant lymph node metastasis and prognosticate outcomes in hepatocellular carcinoma patients[J]. J Gene Med, 2024, 26(9):e3732.
29	Lai Q, De Stefano C, Emond J, et al. Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence[J]. Cancer Commun (Lond), 2023. 43(12):1381-1385.
30	Huang L, Li J, Zhu S, et al. Machine learning-based prognostic prediction and surgical guidance for intrahepatic cholangiocarcinoma[J]. Biosci Trends, 2025,18(6): 545-554.
31	Chen B, Mao Y, Li J, et al. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: a multi-institutional study[J]. Comput Biol Med, 2023, 167: 107612.
32	Lee KS, Jang JY, Yu YD, et al. Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective cohort study[J]. Int J Surg, 2021, 93: 106050.
33	Hu K, Bian C, Yu J, et al. Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images[J]. BMC Gastroenterol, 2024, 24(1): 387.
34	Li B, Wang B, Zhuang P, et al. A novel staging system derived from natural language processing of pathology reports to predict prognostic outcomes of pancreatic cancer: a retrospective cohort study[J]. Int J Surg, 2023, 109(11): 3476-3489.
35	Abou-Alfa GK, Blanc JF, Miles S, et al., Phase Ⅱ study of first-line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma[J]. Oncologist, 2017, 22(7): 780-e65.
36	Li Y, Xiong J, Hu Z, et al. Denoised recurrence label-based deep learning for prediction of postoperative recurrence risk and sorafenib response in HCC[J]. BMC Med, 2025, 23(1): 162.
37	Llovet JM, Castet F, Heikenwalder M, et al. Immunotherapies for hepatocellular carcinoma[J]. Nat Rev Clin Oncol, 2022, 19(3): 151-172.
38	Chen B, Garmire L, Calvisi DF, et al. Harnessing big 'omics’ data and AI for drug discovery in hepatocellular carcinoma[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(4): 238-251.
39	Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial[J]. Lancet, 2018, 391(10126): 1163-1173.
40	Bo Z, Chen B, Zhao Z, et al. Prediction of response to lenvatinib monotherapy for unresectable hepatocellular carcinoma by machine learning radiomics: a multicenter cohort study[J]. Clin Cancer Res, 2023, 29(9): 1730-1740.
41	Von Hoff DD, Ervin T, Arena FP, et al., Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine[J]. N Engl J Med, 2013, 369(18): 1691-1703.
42	Watson MD, Baimas-George MR, Murphy KJ, et al. Pure and hybrid deep learning models can predict pathologic tumor response to neoadjuvant therapy in pancreatic adenocarcinoma: a pilot study[J]. Am Surg, 2021. 87(12): 1901-1909.
43	Gabay M, Li Y, Felsher DW. MYC activation is a hallmark of cancer initiation and maintenance[J]. Cold Spring Harb Perspect Med, 2014, 4(6).
44	Dong B, Zhang Y, Gao H, et al. Machine learning developed a MYC expression feature-based signature for predicting prognosis and chemoresistance in pancreatic adenocarcinoma[J]. Biochem Genet, 2024, 62(5): 4191-4214.
45	Gong M, Jiang Y, Sun Y, et al. Knowledge domain and frontier trends of artificial intelligence applied in solid organ transplantation: a visualization analysis[J]. Int J Med Inform, 2025, 195:105782.
46	Jaremko JL, Azar M, Bromwich R, et al. Canadian association of radiologists white paper on ethical and legal issues related to artificial intelligence in radiology[J]. Can Assoc Radiol J, 2019, 70(2): 107-118.
47	Tozsin A, Ucmak H, Soyturk S, et al. The role of artificial intelligence in medical education: a systematic review[J]. Surg Innov, 2024, 31(4): 415-423.
48	Xu Y, Jiang Z, Ting, DSW, et al. Medical education and physician training in the era of artificial intelligence[J]. Singapore Med J, 2024, 65(3): 159-166.

[1]	Xiaofang Fu, Qinghan Yang, Changqin Sun, Mengjie Dou, Junpu Hu, Hao Sun, Faqin Lyu. Clinical value of a YOLO 11-based ultrasound detection model for limb long bone fracture ends [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2025, 22(06): 541-546.
[2]	Fang Liu, Zhan Zhang, Hui Liu, Ling Fang, Aizhen Wang, Doudou Ding, Miao Cui, Bailing Liu, Jie Wang. Echocardiographic characteristics and outcomes of primary cardiac tumors in children: a singlecentre retrospective study [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2025, 22(05): 470-476.
[3]	Guannan He, Ying Tan, Yuhuan Lu, Bin Pu, Shuihua Yang, Rentie Zhang, Ming Chen, Zhihong Shi, Xiaohong Zhong, Xi Chen, Liuyi Yan, Shengli Li. Application of artificial intelligence in quality control of standard views for fetal echocardiography: a multi-center study [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2025, 22(05): 388-396.
[4]	Feng Gao, Shaolong Hao, Hao Sun, Wei Han. Research progress of tertiary lymphoid structures in pancreatic cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(05): 570-573.
[5]	Cong Zhang, Cheng Li. Research progress on the prognosis status and related factors of surgical treatment for malignant tumors in the pancreatic head region [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(05): 574-578.
[6]	Wei Zhang, Yuntao Li, Peizhong Shang, Zhifang Jia, Wei Zhang, Weilin Guo. A case report of laparoscopic radical resection for metastatic gallbladder cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(05): 589-590.
[7]	Haitao Sun, Lang Ji, Shaolong Hao, Yang Hu, Hao Sun, Yu Ji, Fang Nie, Wei Han. Expression and clinical significance of BANCR in pancreatic cancer tissues and peripheral blood [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(05): 496-500.
[8]	Shaofeng Wu, Mao Wang, Hailong Ma, Ying Shi, Yinghai Dao. Clinical study on the impact of tumor regression grading after neoadjuvant therapy on the efficacy of TME in patients with locally advanced rectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(05): 535-538.
[9]	Qiyin Xu, Shangzhi Han. Impact of preoperative combined with postoperative nutritional support on rehabilitation of patients with rectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(05): 543-546.
[10]	Bingtao Lin, Juntian Chen. Clinical characteristics of patients with advanced gastric cancer of different pathological types and influencing factors of short-term prognosis after laparoscopic-assisted radical resection [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(04): 429-433.
[11]	Qiang Yuan, Wenrui Xiang, Yuan Lv, Zhangzhe Yan, Hanfang Zhu, Guang Chen, Liang Sun, Gang Chen, Suo Zhao. Study on prediction model of recurrence-free survival for gastrointestinal stromal tumors based on random survival forest [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(04): 438-441.
[12]	Xia An, Yusheng Shi, Zhixin Song. Analysis of laboratory detection strategies and clinical value for early screening of colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(04): 446-448.
[13]	Lingjie Wang, Aiping Wang, Chaojun Li, Yueyou Ding, Deye Yang, Qing Zhao, Zhaoqiang Cui, Jingkun Wang, Hongyu Wang. Expert Consensus on Research and Development Strategies for Innovative Heart and Vascular Health Technologies (2024, Shanghai) [J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(05): 323-336.
[14]	Shilun Wu, Changyu Yao, Li Xu, Zhishan Di, Qi Xia, Wenbing Sun, Jian Kong. Progress in understanding the role of tumor-associated macrophages in hepatocellular carcinoma angiogenesis [J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(05): 388-391.
[15]	Xingtong Wei, Haochang Li, Xin Zhao. Contrast-enhanced ultrasound in differential diagnosis of primary liver cancer subtypes: current advances [J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(05): 392-396.

Please choose a citation manager

Content to export